These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29226625)

  • 61. Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation.
    Seong D; Jeong M; Seo J; Lee JY; Hwang CH; Shin HC; Shin JY; Nam YW; Jo JY; Lee H; Kim HJ; Kim HR; Oh JH; Ha SJ; Kim SJ; Roe JS; Kim W; Cheong JW; Bae KH; Lee SC; Oberst A; Vandenabeele P; Shin DH; Lee EW; Song J
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):19982-19993. PubMed ID: 32753382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB.
    Webb LV; Barbarulo A; Huysentruyt J; Vanden Berghe T; Takahashi N; Ley S; Vandenabeele P; Seddon B
    Immunity; 2019 Feb; 50(2):348-361.e4. PubMed ID: 30737145
    [TBL] [Abstract][Full Text] [Related]  

  • 63. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
    Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
    J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.
    Lusthaus M; Mazkereth N; Donin N; Fishelson Z
    Front Immunol; 2018; 9():306. PubMed ID: 29527209
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.
    Saleh D; Degterev A
    Curr Top Microbiol Immunol; 2017; 403():37-75. PubMed ID: 26385769
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monitoring RIPK1 Phosphorylation in the TNFR1 Signaling Complex.
    Priem D; Dondelinger Y; Bertrand MJM
    Methods Mol Biol; 2018; 1857():171-179. PubMed ID: 30136241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Research on Potential Role of Receptor-interacting Protein Kinase 1 in Phenotype Switching of Vascular Smooth Muscle Cells].
    Bao Q; Chen L; Wu S; Zhao M; Wu W; Fu H; Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Aug; 33(4):719-28. PubMed ID: 29714912
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
    Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
    Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
    [TBL] [Abstract][Full Text] [Related]  

  • 69. StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1.
    Dillon CP; Balachandran S
    Cytokine; 2016 Feb; 78():47-50. PubMed ID: 26630177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis.
    Newton K; Wickliffe KE; Dugger DL; Maltzman A; Roose-Girma M; Dohse M; Kőműves L; Webster JD; Dixit VM
    Nature; 2019 Oct; 574(7778):428-431. PubMed ID: 31511692
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways.
    Liang S; Nian Z; Shi K
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1028-1035. PubMed ID: 32321638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kinase-independent role of nuclear RIPK1 in regulating parthanatos through physical interaction with PARP1 upon oxidative stress.
    Jang KH; Jang T; Son E; Choi S; Kim E
    Biochim Biophys Acta Mol Cell Res; 2018 Jan; 1865(1):132-141. PubMed ID: 28993228
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
    Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis.
    Yang X; Lu H; Xie H; Zhang B; Nie T; Fan C; Yang T; Xu Y; Su H; Tang W; Zhou B
    Angew Chem Int Ed Engl; 2022 Jan; 61(5):e202114922. PubMed ID: 34851543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Revealing the Kinetic Advantage of a Competitive Small-Molecule Immunoassay by Direct Detection.
    Tran RJ; Sly KL; Conboy JC
    Anal Chem; 2020 Oct; 92(19):13163-13171. PubMed ID: 32878441
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular modeling provides a structural basis for PERK inhibitor selectivity towards RIPK1.
    Chintha C; Carlesso A; Gorman AM; Samali A; Eriksson LA
    RSC Adv; 2019 Dec; 10(1):367-375. PubMed ID: 35558862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Target occupancy biomarker assay development using a conformation-selective antibody against small-molecule-bound TNF.
    Hickford ES; O'Connell J; Maloney A; Florian P; Johnston GI; Rospo CC; Herrmann M; Wright S; Bourne T
    Bioanalysis; 2023 Mar; 15(6):343-359. PubMed ID: 37026566
    [No Abstract]   [Full Text] [Related]  

  • 79. Importance of Quantifying Drug-Target Engagement in Cells.
    Stefaniak J; Huber KVM
    ACS Med Chem Lett; 2020 Apr; 11(4):403-406. PubMed ID: 32292539
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers.
    Weisel K; Scott NE; Tompson DJ; Votta BJ; Madhavan S; Povey K; Wolstenholme A; Simeoni M; Rudo T; Richards-Peterson L; Sahota T; Wang JG; Lich J; Finger J; Verticelli A; Reilly M; Gough PJ; Harris PA; Bertin J; Wang ML
    Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.